BSECompany Update▲ PositiveResults5 Aug 2026
RSWM Ltd
Investor Presentation
RSWM Ltd has announced its unaudited financial results for the quarter ended 30th June, 2026, with revenue of ₹1,161 crore, EBITDA of ₹94 crore, and Profit After Tax (PAT) of ₹17 crore, driven by operational excellence, improved product mix, and disciplined cost management.
NSEInvestor Presentation▲ PositiveResults5 Aug 2026
RSWM Limited
Investor Presentation
RSWM Limited has informed the Exchange about Investor Presentation for the unaudited Financial Results of the Company for the quarter ended 30th June, 2026.
BSECompany Update▲ PositiveResults5 Aug 2026
Global Health Ltd
Announcement under Regulation 30 of Listing Regulations,2015 for Earning Conference call Transcript.
Global Health Ltd (Medanta) has released the transcript of its Q1 FY27 Earnings Conference Call, highlighting its focus on clinical excellence, patient-centric care, and operational growth.
NSEPress Release▲ PositiveResults5 Aug 2026
Biocon Limited
Press Release
Biocon Limited announced its consolidated financial results for the fiscal first quarter ended June 30, 2026, with a total income of Rs 4,391 Cr, up 9% YoY, driven by strong growth in the Biopharma business. The company reported a net profit of Rs 141 Cr, up 355% YoY.
BSECompany Update▲ PositiveResults5 Aug 2026
Biocon Ltd
Press Release
Biocon Ltd announced its consolidated financial results for Q1FY27, with total income at Rs 4,391 Cr, up 9% YoY, driven by strong growth in the Biopharma business. Biopharma revenue grew 17% YoY, driven by momentum from recent biosimilar and generic product launches across key markets.
BSEBoard Meeting▲ PositiveResults5 Aug 2026
Biocon Ltd
Outcome of Board Meeting
Biocon Ltd announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 638 million and a basic earnings per share of Rs. 0.32. The company's consolidated financial results also showed a net profit of Rs. 1,368 million. The results will be available on the company's website.
BSECompany Update▲ PositiveResults5 Aug 2026
Hindalco Industries Ltd
Please find enclosed herewith Earnings Presentation of Novelis Inc. (wholly owned subsidiary) for its Q1FY27 results
Hindalco Industries' wholly-owned subsidiary Novelis Inc. reported Q1FY27 results, with net income attributable to common shareholder up 71% YoY to $164 million, driven by favorable metal price lag and lower aluminum scrap prices.
NSEInvestor Presentation▲ PositiveResults5 Aug 2026
Hindalco Industries Limited
Investor Presentation
Hindalco Industries Limited's wholly-owned subsidiary Novelis Inc. has published its Q1 FY27 results, with net income attributable to common shareholders increasing 71% YoY to $164 million, and Adjusted EBITDA increasing 24% YoY to $516 million.
NSEPress Release▲ PositiveResults5 Aug 2026
Hindalco Industries Limited
Press Release
Hindalco's subsidiary Novelis reports Q1 FY27 results with net income attributable to common shareholder up 71% YoY, driven by favorable metal price lag and cost efficiencies. Net sales increased 23% YoY to $5.8 billion.
BSECompany Update▲ PositiveResults5 Aug 2026
Hindalco Industries Ltd
Please find enclosed herewith News Release issued by Novelis Inc. (wholly owned subsidiary) for Q1 FY27 results
Hindalco Industries Ltd's wholly owned subsidiary Novelis Inc. reported Q1 FY27 results with net income attributable to common shareholder up 71% YoY and Adjusted EBITDA up 24% YoY.
BSEResult▲ PositiveResults5 Aug 2026
Biocon Ltd
Outcome of Board Meeting- Financial Results
Biocon Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, showing a net profit of Rs. 522 million. The company's revenue from operations was Rs. 6,245 million, and its expenses were Rs. 6,194 million. The results are available on the company's website.
BSEBoard Meeting▲ PositiveResults5 Aug 2026
Gujarat Narmada Valley Fertilizers & Chemicals Ltd
Outcome of Board Meeting
Gujarat Narmada Valley Fertilizers & Chemicals Ltd announced its unaudited standalone and consolidated financial results for the first quarter of FY 2026-27, ended on June 30, 2026. The company reported a net profit of ₹310 crore, with a basic earnings per share of ₹21.09.
BSECompany Update▲ PositiveResults5 Aug 2026
Navin Fluorine International Ltd-$
Investor Presentation for Q1 of FY 2026-27
Navin Fluorine International Ltd has released its Q1 FY 2026-27 investor presentation, highlighting a 44% YoY revenue growth, 11% QoQ revenue growth, and 73% YoY EBITDA growth. The company's business verticals, HPP, Specialty Chemicals, and CDMO, have shown significant growth, with HPP revenue increasing by 33%, Specialty Chemicals by 48%, and CDMO by 82%. The company has also announced plans to commission additional HFC capacity and de-bottleneck MPP capacity.
NSEInvestor Presentation▲ PositiveResults5 Aug 2026
Navin Fluorine International Limited
Investor Presentation
Navin Fluorine International Limited has informed the Exchange about Investor Presentation for Q1 of Financial Year 2026-27, with business highlights including 44% YoY revenue growth, 11% QoQ growth, and 73% YoY growth in HPP segment.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults5 Aug 2026
National Aluminium Company Limited
Analysts/Institutional Investor Meet/Con. Call Updates
National Aluminium Company Limited has announced its Q1 FY27 earnings, with a 39% growth in total income and 88% growth in PBT, driven by a substantial increase in revenue collection and profitability. The company has achieved its targets in production and has recorded its best ever quarter in bauxite, hydrate production, and wind power generation.
BSECompany Update▲ PositiveResults5 Aug 2026
National Aluminium Company Ltd
Transcript of the Earnings Conference Call held on 03.08.2026
National Aluminium Company Ltd has announced its Q1 FY27 earnings, with a 39% growth in total income and 88% growth in PBT, driven by improved production volumes and capacity utilization.
BSEResult▲ PositiveResults5 Aug 2026
Navin Fluorine International Ltd-$
Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026
Navin Fluorine International Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company has reported a total revenue of ₹1,045.08 crore, with expenses of ₹442.42 crore. The net profit for the quarter is ₹318.36 crore. The company has also approved a capital expenditure of ₹90 crores for establishing adoption capacities to progress products forming part of its Advanced Materials portfolio.
NSEInvestor Presentation▲ PositiveResults5 Aug 2026
Neuland Laboratories Limited
Investor Presentation
Neuland Laboratories Limited has presented its Q1FY27 financial results, showing a 116.3% YoY increase in total income to Rs. 650.1 crore, with EBITDA margin increasing by 2150 bps YoY to 35.5%. The company's net debt stood at Rs. (308.5) crore as at Q1FY27 end.
BSECompany Update▲ PositiveResults5 Aug 2026
Neuland Laboratories Ltd
Investor Presentation on the Financial Results of the Company for the quarter ended June 30, 2026
Neuland Laboratories Ltd has announced its Q1FY27 financial results, with total income at Rs. 650.1 crore, EBITDA at Rs. 231.1 crore, and PAT at Rs. 147.4 crore, showing significant year-over-year growth. The company's working capital days of sale decreased to 84 days in Q1FY27 from 137 days in Q4FY26, and capex outflow was Rs. 122 Cr in Q1FY27.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults5 Aug 2026
Kalpataru Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Kalpataru Limited has informed the Exchange about the Transcript of Earnings conference call on Unaudited Standalone and Consolidated Financial Results for the first quarter ended June 30, 2026. The company delivered a steady start to the fiscal year, driven by operational momentum, robust sales collections, strategic projects launches, and continued execution across core micro-markets.